Dynasty Wealth Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.97M Sell
10,075
-84
-0.8% -$16.3K 0.02% 129
2025
Q4
$1.76M Buy
10,159
+411
+4% +$74.8K 0.02% 143
2025
Q3
$1.86M Buy
+9,748
New +$1.73M 0.02% 123

Other funds holding DGX

Dynasty Wealth Management's DGX Position: Q1 2026 in Review

Dynasty Wealth Management reduced its Quest Diagnostics (DGX) stake by 0.83% in Q1 2026, selling an estimated $16.3K and leaving 10,075 shares worth $1.97M. The position accounts for 0.02% of the portfolio, ranked #129.

Dynasty Wealth Management first reported a position in DGX in Q3 2025 and has held it in 3 quarters since. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Dynasty Wealth Management held 10,075 shares of Quest Diagnostics worth $1.97M as of Q1 2026.
  • Dynasty Wealth Management sold 84 Quest Diagnostics shares in Q1 2026, an estimated $16.3K.
  • Quest Diagnostics made up 0.02% of Dynasty Wealth Management's portfolio in Q1 2026, its #129 holding.
  • Dynasty Wealth Management first reported a position in Quest Diagnostics in Q3 2025 and has held it in 3 quarters since.
  • 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Dynasty Wealth Management's 13F filing for Q1 2026, filed 14 May 2026.